Australia markets open in 3 hours 43 minutes

IN8bio, Inc. (INAB)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.0900-0.1000 (-8.40%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 52.51M
Enterprise value 45.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.00
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-56.41%
S&P500 52-week change 323.49%
52-week high 33.0500
52-week low 30.6500
50-day moving average 31.0682
200-day moving average 31.1203

Share statistics

Avg vol (3-month) 3333.86k
Avg vol (10-day) 395.67k
Shares outstanding 544.12M
Implied shares outstanding 644.12M
Float 825.25M
% held by insiders 122.86%
% held by institutions 139.92%
Shares short (15 May 2024) 4105.53k
Short ratio (15 May 2024) 40.64
Short % of float (15 May 2024) 40.40%
Short % of shares outstanding (15 May 2024) 40.24%
Shares short (prior month 15 Apr 2024) 4512.02k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-78.29%
Return on equity (ttm)-180.94%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -29.61M
Net income avi to common (ttm)-31.04M
Diluted EPS (ttm)-0.9000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.02M
Total cash per share (mrq)0.29
Total debt (mrq)5.71M
Total debt/equity (mrq)32.61%
Current ratio (mrq)4.10
Book value per share (mrq)0.41

Cash flow statement

Operating cash flow (ttm)-23.82M
Levered free cash flow (ttm)-12.24M